Published in Ann Neurol on November 01, 1985
Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis | NCT01856205
Japanese encephalitis. J Neurol Neurosurg Psychiatry (2000) 2.76
Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J Virol (2002) 1.44
A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal. PLoS One (2015) 1.44
Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol (1997) 1.40
Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J Virol (1997) 1.35
Arboviral encephalitides: transmission, emergence, and pathogenesis. J Neuroimmune Pharmacol (2010) 1.24
Viruria during acute Japanese encephalitis virus infection. Int J Exp Pathol (1995) 1.23
Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol (1991) 1.17
An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis. J Neurol (2009) 1.14
Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am J Pathol (1989) 1.12
Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol (1991) 1.10
Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int J Exp Pathol (1992) 1.08
Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol (2004) 1.00
Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages. Clin Exp Immunol (1991) 0.95
Degradation of Japanese encephalitis virus by neutrophils. Int J Exp Pathol (1999) 0.91
Neuropathogenesis of Japanese encephalitis in a primate model. PLoS Negl Trop Dis (2014) 0.89
Immunohistochemical demonstration of viral antigens in Japanese encephalitis. Acta Neuropathol (1986) 0.88
Indirect role of T cells in development of polioencephalitis and encephalomyelitis induced by encephalomyocarditis virus. J Virol (1991) 0.87
The involvement of microglial cells in Japanese encephalitis infections. Clin Dev Immunol (2012) 0.85
Characterization of nonstructural protein 3 of a neurovirulent Japanese encephalitis virus strain isolated from a pig. Virol J (2011) 0.83
The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system. Arch Virol (2012) 0.83
Unusual acute encephalitis involving the thalamus: imaging features. Korean J Radiol (2001) 0.83
Stimulation of neutrophil respiratory burst and degranulation by Japanese encephalitis virus-induced macrophage derived factor. Int J Exp Pathol (1993) 0.82
Cellular inflammatory response to flaviviruses in the central nervous system of a primate host. J Histochem Cytochem (2009) 0.82
Susceptibility of human embryonic stem cell-derived neural cells to Japanese encephalitis virus infection. PLoS One (2014) 0.80
Temporal changes of Japanese encephalitits virus in different brain regions of rat. Indian J Med Res (2013) 0.79
Japanese Encephalitis Complicated with Obstructive Hydrocephalus. J Clin Diagn Res (2016) 0.75
Phenotypes of mononuclear cell infiltrates in human central nervous system. Acta Neuropathol (1993) 0.75
Meningitis Caused by Toscana Virus Is Associated with Strong Antiviral Response in the CNS and Altered Frequency of Blood Antigen-Presenting Cells. Viruses (2015) 0.75
Epidemiological study of Japanese encephalitis virus in Vientiane, Lao PDR, in 1990s. ScientificWorldJournal (2015) 0.75
Regulation of inflammation in Japanese encephalitis. J Neuroinflammation (2017) 0.75
Japanese Encephalitis Virus Infection Results in Transient Dysfunction of Memory Learning and Cholinesterase Inhibition. Mol Neurobiol (2016) 0.75
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg (1989) 10.52
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med (1977) 8.24
Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12
Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature (1970) 5.90
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Neurological manifestations of dengue infection. Lancet (2000) 5.69
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) (1968) 4.40
Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature (1970) 4.21
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12
Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis (1977) 3.51
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Detection of diverse HIV-1 genetic subtypes in the USA. Lancet (1995) 3.41
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg (1999) 3.11
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol (1996) 2.83
Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Engl J Med (1987) 2.81
Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59
Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59
Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis (1972) 2.56
The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev (1992) 2.56
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 2.52
Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol (1998) 2.50
Pathogenesis of viral infections of the nervous system. N Engl J Med (1968) 2.48
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis (1994) 2.42
Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet (1998) 2.41
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/. Nature (1994) 2.35
Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol (1977) 2.32
Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (1988) 2.31
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Complementation analysis on virus-fused Chinese hamster cells with nutritional markers. Science (1969) 2.12
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science (1996) 2.11
Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol (2001) 2.09
Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg (1969) 2.07
False-positive Western blot tests for antibodies to HTLV-III. JAMA (1986) 2.07
Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol (2002) 2.04
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04
Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med (1988) 2.03
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses (1994) 1.90
Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90
Direct measurement of human immunodeficiency virus seroconversions in a serially tested population of young adults in the United States Army, October 1985 to October 1987. Walter Reed Retrovirus Research Group. N Engl J Med (1989) 1.89
Viral infections and demyelinating diseases. N Engl J Med (1973) 1.84
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine (2001) 1.79
Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus. Clin Diagn Lab Immunol (1997) 1.78
Molecular and epidemiologic analysis of dengue virus isolates from Somalia. Emerg Infect Dis (1998) 1.77
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75
Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluorescent antibody staining. J Neuropathol Exp Neurol (1965) 1.72
HIV-1 genetic diversity. AIDS (1996) 1.69
Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol (1969) 1.68
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol (1980) 1.68
Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg (2001) 1.65
A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes. J Cell Biol (1995) 1.65
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA (1993) 1.63
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
Nucleo-cytoplasmic interactions in the acheivement of nuclear synchrony in DNA synthesis and mitosis in multinucleate cells. Biol Rev Camb Philos Soc (1971) 1.61
Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis (1988) 1.59
Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA (1987) 1.59
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59